{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:00:52Z","timestamp":1791986452678,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bcp.2019.113775","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T11:44:35Z","timestamp":1576842275000},"page":"113775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Hydrogen sulfide modulates epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via HIF-1\u03b1 activation"],"prefix":"10.1016","volume":"172","author":[{"given":"Mingqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.113775_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/513S1a","article-title":"Lung cancer","volume":"513","author":"Brody","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.113775_b0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.21873\/anticanres.11330","article-title":"Immune-based Therapies for Non-small Cell Lung Cancer","volume":"37","author":"Rafei","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2019.113775_b0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bcp.2019.113775_b0020","article-title":"The cardioprotective actions of hydrogen sulfide in acute myocardial infarction and heart failure","volume":"2014","author":"Polhemus","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.bcp.2019.113775_b0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/ars.2009.2938","article-title":"Hydrogen sulfide: the third gasotransmitter in biology and medicine","volume":"12","author":"Wang","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bcp.2019.113775_b0030","first-page":"4","article-title":"Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists","volume":"59","author":"Lowicka","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bcp.2019.113775_b0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szabo","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2019.113775_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00726-010-0510-x","article-title":"Hydrogen sulfide: its production, release and functions","volume":"41","author":"Kimura","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2019.113775_b0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/ars.2013.5339","article-title":"Enzymology of H2S biogenesis, decay and signaling","volume":"20","author":"Kabil","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bcp.2019.113775_b0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/03008207.2015.1060970","article-title":"The role of EMT and MET in cancer dissemination","volume":"56","author":"Banyard","year":"2015","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.bcp.2019.113775_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2015.01.004","article-title":"Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation","volume":"150","author":"Li","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2019.113775_b0060","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/1878-0261.12091","article-title":"EMT: Present and future in clinical oncology","volume":"11","author":"Santamaria","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.bcp.2019.113775_b0065","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2019.113775_b0070","first-page":"277","article-title":"Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells","volume":"31","author":"Kajiyama","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2019.113775_b0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Zeisberg","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2019.113775_b0080","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1158\/1078-0432.CCR-11-1185","article-title":"Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype","volume":"17","author":"Carbone","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2019.113775_b0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/path.4546","article-title":"Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment","volume":"236","author":"Suarez-Carmona","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.bcp.2019.113775_b0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-18144-8_12","article-title":"Hydrogen Sulfide and Cancer","volume":"230","author":"Hellmich","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bcp.2019.113775_b0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2015.08.004","article-title":"Hydrogen sulfide in cancer: Friend or foe?","volume":"50","author":"Wu","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2019.113775_b0100","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2019.113775_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2019.113775_b0110","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3892\/ijo.2014.2305","article-title":"GYY4137, a hydrogen sulfide (H(2)S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway","volume":"44","author":"Lu","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2019.113775_b0115","article-title":"H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S?","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2019.113775_b0120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/j.2040-4603.2016.tb00698.x","article-title":"Lung Structure and the Intrinsic Challenges of Gas Exchange","volume":"6","author":"Hsia","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.bcp.2019.113775_b0125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1242\/dev.098186","article-title":"Lung development: orchestrating the generation and regeneration of a complex organ","volume":"141","author":"Herriges","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bcp.2019.113775_b0130","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.3390\/ijms20163975","article-title":"Hydrogen Sulfide Attenuates Hydrogen Peroxide-Induced Injury in Human Lung Epithelial A549 Cells","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bcp.2019.113775_b0135","doi-asserted-by":"crossref","first-page":"36125","DOI":"10.1038\/srep36125","article-title":"Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics","volume":"6","author":"Szczesny","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2019.113775_b0140","article-title":"Oxaloacetate Ameliorates Chemical Liver Injury via Oxidative Stress Reduction and Enhancement of Bioenergetic","volume":"19","author":"Kuang","year":"2018","journal-title":"Fluxes"},{"key":"10.1016\/j.bcp.2019.113775_b0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbrc.2013.02.131","article-title":"Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate sulfurtransferase\/hydrogen sulfide pathway","volume":"433","author":"Modis","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2019.113775_b0150","doi-asserted-by":"crossref","first-page":"65677","DOI":"10.18632\/oncotarget.20057","article-title":"Cystathionine- gamma-lyase promotes process of breast cancer in association with STAT3 signaling pathway","volume":"8","author":"You","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.113775_b0155","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S1470-2045(18)30495-9","article-title":"Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials","volume":"19","author":"Fang","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bcp.2019.113775_b0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/biof.1061","article-title":"H2S: a \u201cdouble face\u201d molecule in health and disease","volume":"39","author":"Di Masi","year":"2013","journal-title":"BioFactors"},{"key":"10.1016\/j.bcp.2019.113775_b0165","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41598-017-05457-z","article-title":"Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2019.113775_b0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.acc.2016.07.005","article-title":"Hydrogen Sulfide as a \u201cDouble-Faced\u201d Compound: One with Pro- and Antioxidant Effect","volume":"78","author":"Olas","year":"2017","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.bcp.2019.113775_b0175","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bph.12171","article-title":"Selectivity of commonly used pharmacological inhibitors for cystathionine beta synthase (CBS) and cystathionine gamma lyase (CSE)","volume":"169","author":"Asimakopoulou","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2019.113775_b0180","first-page":"2069","article-title":"MiR-15a expression analysis in non-small cell lung cancer A549 cells under local hypoxia microenvironment","volume":"21","author":"Jing","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bcp.2019.113775_b0185","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1172\/JCI84430","article-title":"Hypoxia-inducible factors: a central link between inflammation and cancer","volume":"126","author":"Triner","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2019.113775_b0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/01902148.2019.1571124","article-title":"Hyperbaric oxygen rescues lung cancer cells from chemical hypoxia-induced low differentiation and apoptosis resistance","volume":"44","author":"Wang","year":"2018","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.bcp.2019.113775_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/549412","article-title":"Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies","volume":"2015","author":"Zimna","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bcp.2019.113775_b0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3389\/fonc.2018.00631","article-title":"Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8(+) T Cells in Non-small Cell Lung Cancer","volume":"8","author":"Ye","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.bcp.2019.113775_b0205","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2019.113775_b0210","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/ars.2014.5901","article-title":"Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics","volume":"22","author":"Wallace","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bcp.2019.113775_b0215","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1089\/ars.2009.2882","article-title":"Novel insights into hydrogen sulfide\u2013mediated cytoprotection","volume":"12","author":"Calvert","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bcp.2019.113775_b0220","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.113775_b0225","first-page":"222","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bcp.2019.113775_b0230","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jnr.23427","article-title":"Hydrogen sulfide treatment induces angiogenesis after cerebral ischemia","volume":"92","author":"Jang","year":"2014","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bcp.2019.113775_b0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vph.2017.05.004","article-title":"A critical role for cystathionine-beta-synthase in hydrogen sulfide-mediated hypoxic relaxation of the coronary artery","volume":"93\u201395","author":"Donovan","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.bcp.2019.113775_b0240","first-page":"1299","article-title":"Protective effect of a hydrogen sulfide donor on balloon injury-induced restenosis via the Nrf2\/HIF-1alpha signaling pathway","volume":"43","author":"Ling","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2019.113775_b0245","doi-asserted-by":"crossref","first-page":"C305","DOI":"10.1152\/ajpcell.00230.2015","article-title":"Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2\/mTOR pathway","volume":"310","author":"Zhou","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bcp.2019.113775_b0250","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.juro.2016.01.113","article-title":"Hydrogen Sulfide Induced Erythropoietin Synthesis is Regulated by HIF Proteins","volume":"196","author":"Leigh","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.bcp.2019.113775_b0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-018-0730-6","article-title":"Inflammatory interferon activates HIF-1alpha-mediated epithelial-to-mesenchymal transition via PI3K\/AKT\/mTOR pathway","volume":"37","author":"Yeh","year":"2018","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:12:06Z","timestamp":1757769126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219304745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":51,"alternative-id":["S0006295219304745"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113775","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogen sulfide modulates epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via HIF-1\u03b1 activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113775"}}